CCL2 and neoplasm: Largely tumor derived, CCL2/MCP-1 exerts autocrine-mediated promotion of tumor growth and invasion (53, 54), and paracrine-mediated recruitment of myeloid-derived suppressor cells (MDSCs) that enhance tumor cell survival (55, 56).